Deglutition Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with ischemic stroke for a maximum of 72 hours (acute phase) will be included; confirmed by computed tomography or magnetic resonance imaging; after neurological evaluation; of both sexes; over the age of 18 years; with dysphagia
Exclusion criteria
Exclusion criteria: Individuals with great swallowing impairment before stroke were excluded; previous episodes of stroke; previous dysphagia; associated neurological pathologies; any metal in the cranial cavity; lesions in the area of electrode placement (some skin change in the scalp in the area to be stimulated); metal in use of pacemaker; previous skull surgery; eyes or decompression surgery; use of medications that interfere with cortical excitability (opiates; benzodiazepines); score above 8 on the hospital scale of anxiety and depression (HAD); uncontrolled epileptic seizure; in addition to clinical instability (systolic blood pressure; drop in systolic blood pressure; heart rate; altered consciousness; cold and sticky skin); severe cognitive impairment; global aphasia; previous visual disturbances; ; other associated neurological diseases or possibility of pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction in the degree of severity of dysphagia in subjects with stroke, in the acute phase, for a period of 06 months, verified through the application of transcranial stimulation by direct current, associated with speech therapy, from the observation of a variation of at least 10% in the pre- and post-intervention measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction in the time of use of the alternative feeding route in subjects with stroke in the acute phase for a period of 06 months, verified through the application of transcranial stimulation by direct current, associated with speech therapy, from the observation of a variation of at least 10% in the pre- and post-intervention measurements.;It is expected to find a reduction in the degree of neurological deficits through the National Institute of Health Stroke Scale (NIHSS), which is a standard, validated, safe, quantitative scale of the severity and magnitude of neurological deficit after stroke, that will be applied to the subjects in the acute phase, for a period of 03 consecutive days, verified through the application of transcranial stimulation by direct current, associated with speech therapy, from the observation of a variation of at least 10% in the pre- and post-intervention measurements.;It is expected to find an improvement in quality of life through the instrument Quality of Life in Swallowing Disorders (SWAL-QOL), which is a sensitive self-assessment instrument that allows to know the real impact of the changes experienced at the time of feeding and the perception of the individual about the quality of life in swallowing. This protocol will be applied in subjects with stroke, in the acute phase for a period of 03 consecutive days, through the application of transcranial stimulation by direct current, associated with speech therapy, from the observation of a variation of at least 10% in the pre- and post-intervention measurements.;It is expected to find a reduction in the costs and expenses with hospitalization time due to aspiration pneumonia, in the subjects with stroke, in the acute phase, for a period of 06 months, verified through the application of transcranial stimulation by direct current, associated with speech therapy, from the observation of a variation of at least 10% in the pre- and post-intervention measurements. | — |
Countries
Brazil
Contacts
Universidade Federal do Triângulo Mineiro